Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors.
Fugger K, Bajrami I, Silva Dos Santos M, Young SJ, Kunzelmann S, Kelly G, Hewitt G, Patel H, Goldstone R, Carell T, Boulton SJ, MacRae J, Taylor IA, West SC.
Fugger K, et al. Among authors: carell t.
Science. 2021 Apr 9;372(6538):156-165. doi: 10.1126/science.abb4542.
Science. 2021.
PMID: 33833118
Free PMC article.